- Record: found
- Abstract: not found
- Article: not found
HL-398: Five-year overall survival from the CheckMate 205 study of nivolumab for relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL)
S Ansell, P. Brockelmann, G von Keudell, HJ Lee, A Santoro, PL Zinzani, G Collins, J Cohen, JP de Boer, J. Kuruvilla, A. SANTORO, Stephen Ansell, Paul Bröckelmann, Gottfried von Keudell, Hun Ju Lee, Armando Santoro, Pier Luigi Zinzani, Graham Collins, Jonathon Cohen, Jan Paul de Boer, John Kuruvilla, Kerry J. Savage, Marek Trneny, Mariano Provencio, Ulrich Jaeger, Wolfgang Willenbacher, Rene Swanink, Margaret A. Shipp, Andreas Engert, Philippe Armand
2021
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.